Novavax joins Oxford mix-and-match COVID-19 vaccine study in…
The Phase II clinical trial will include at least 360 adolescents aged 12-16 years old - News - PharmaTimes
by Lucy Parsons|Lucy Parsons
https://www.pharmatimes.com/news/novavax_joins_oxford_mix-and-match_covid-19_vaccine_study_in_adolescents_1377743